Arkolith/Insider Trading/KTTA/Form 4

Dumesnil Simon

DirectorPasithea Therapeutics Corp. (KTTA) · full profile →Form 4 · filed Nov 17, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2022Grant(A)40K$1.06$42K50K
Nov 15, 2022Grant(A)10K$1.07$11K10K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 2, 2021Grant(A)100K—$0100K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-22-073502) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML